Fredun Pharmaceuticals Ltd EPS

Fredun Pharmaceuticals Ltd EPS

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

EPS

₹ 26.5

Last updated on: Sep 25, 2026

Key Highlights

  • The Earning per Share of Fredun Pharmaceuticals Ltd is ₹ 26.5 as of 25 Sep 26 The earning per share of Fredun Pharmaceuticals Ltd changed from ₹ 29.09 to ₹ 23.82 over 7 quarters. This represents a CAGR of -10.79% .

Historical Earning per Share of Fredun Pharmaceuticals Ltd

No data available

* All values are in ₹

Company Fundamentals for Fredun Pharmaceuticals Ltd

Market Cap

2,250 Cr

EPS

26.5

P/E Ratio (TTM)

51.3

P/B Ratio (TTM)

8.4

Day’s High

1384.7

Day’s Low

1340.0

DTE

0.8

ROE

11.7

52 Week High

1600.0

52 Week Low

420.16

ROCE

17.2

Market Price of Fredun Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Fredun Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Sep 20261360.9
24 Sep 20261360.2
23 Sep 20261395.35
22 Sep 20261382.95
21 Sep 20261347.55
18 Sep 20261305.85
17 Sep 20261278.65
16 Sep 20261221.6
15 Sep 20261325.05
11 Sep 20261413.55

SWOT Analysis Of Fredun Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Fredun Pharmaceuticals Ltd

Asset Value vs Market Value of Fredun Pharmaceuticals Ltd

Market Value

₹ 2,251

Asset Value

Value addition

3.5 X

₹ 498

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Fredun Pharmaceuticals Ltd2250
Sun Pharmaceutical Industries Ltd444717
Divis Laboratories Ltd255115
Torrent Pharmaceuticals Ltd189613
Zydus Lifesciences Ltd119900
Cipla Ltd112876

Historical Market Cap of Fredun Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Historical Revenue of Fredun Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Historical EBITDA of Fredun Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Historical Net Profit of Fredun Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Fredun Pharmaceuticals Ltd News Hub

Fredun Pharmaceuticals AGM scheduled

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held o

Read more

19 Sept 24

Fredun Pharmaceuticals to hold AGM

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held o

Read more

19 Sept 24

Fredun Pharmaceuticals to hold board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 October 202

Read more

27 Sept 24

Fredun Pharmaceuticals to discuss results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 October 20

Read more

16 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Fredun Pharmaceuticals Ltd

What is the EPS of Fredun Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Fredun Pharmaceuticals Ltd is 26.5. An EPS is the amount of net income attributed to each share of a common stock.

How is Fredun Pharmaceuticals Ltd EPS calculated?

The EPS of Fredun Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Fredun Pharmaceuticals Ltd report its EPS?

Fredun Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Fredun Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Fredun Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Fredun Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Fredun Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions